Questor is The Telegraph’s stockpicking column, helping you decode the markets and offering insights on where to invest for ...

The 2024 increase is the same as last year.The foundation’s annual survey of employer health benefits also found that only 18 ...

LONDON and NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicine company, today announced a poster presentation at ...

The COVID-19 pandemic made the world realize the importance of investing in healthcare infrastructure and developing treatments for unmet medical needs. The increased focus on healthcare and the ...

A recent research published in the Food Bioscience journal highlighted an critical connection between Type 2 taste receptors ...

For patients with obesity, type 2 diabetes, and estimated glomerular filtration rate (eGFR) 20 to 60 mL/min/1.73 m2, metabolic surgery is associated with a lower risk for progression of kidney ...

A large study of veterans with type 2 diabetes finds better short-term kidney outcomes with use of SGLT2 inhibitors vs GLP-1 receptor agonists.

American adults prefer dietary change as a weight loss method, over injectable weight loss drugs such as Ozempic, a survey says.

While shares have posted break-even returns so far in 2024, Pfizer stock has cratered by more than 30% over the ...

Skye Bioscience (NASDAQ: SKYE) is a micro-cap pharmaceutical company that is striving to become the next big thing in the ...

Facial volume loss and increased skin laxity were significant in the mid-cheek region after major weight loss, resulting in accelerated facial aging.

Doctors have issued a serious health warning over the extremely dangerous ‘faux-zempic’ as the weight loss drugs see an ...